Live Breaking News & Updates on Intrexon corporation

Stay updated with breaking news from Intrexon corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MIT Corporation elects 11 term members, three life members


Credits:
Courtesy of the Office of the Corporation
Previous image
Next image
The MIT Corporation — the Institute’s board of trustees — elected nine full-term members, who will each serve for five years; two partial-term members; and three life members, during its quarterly meeting today. Corporation Chair Diane Greene SM ’78 announced the election results; all positions are effective July 1.
The nine full-term members are: Lindsay Androski ’98; Eran Broshy ’79; Ashton Carter; Fiona Chen ’21; Kevin Churchwell ’83; Grace Colón PhD ’95; Diane Hoskins ’79; Pearl Huang ’80; and Ray Rothrock SM ’78. The two partial-term members are: Michael “Mick” Mountz ’87; and Mark Wrighton. The three life members are: Patricia Callahan ’75, SM ’77; Alan Levanthal; and Kenneth Wang ’71.

New-york , United-states , Malaysia , Hong-kong , Alexandria , Al-iskandariyah , Egypt , Texas , China , Delaware , Boston , Massachusetts

Synthetic Biology Market worth $ 11.00 Billion, Globally, by 2028 at 6.60% % CAGR: Verified Market Research


Synthetic Biology Market worth $ 11.00 Billion, Globally, by 2028 at 6.60% % CAGR: Verified Market Research
- Numerous applications of Synthetic Biology, a decrease in costs of DNA Sequencing and synthesizing, and elevating demand for synthetic genes and synthetic cells contribute as the primary drivers of the growth of the market
JERSEY CITY, N.J., May 11, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Synthetic Biology Market" By Product (Core Products and Enabling Products), By Technology (Gene Synthesis, Genome Engineering, Cloning, Sequencing, Site-Directed Mutagenesis & Others), By Application (Medical Application, Pharmaceuticals, Drug Discovery and Therapeutics, Artificial Tissue and Tissue Regeneration & Others), and by Geography. According to Verified Market Research, the Global Synthetic Biology Market was valued at USD 6.60 Billion in 2020 and is projected to reach USD 11.00 Billion by 2028, growing at a CAGR of 6.60% from 2021 to 2028.

Jersey , Mexico , Germany , United-states , United-kingdom , California , Canada , France , America , Kostenloser-wertpapierhandel , Brammer-bio , Asia-pacific

Synthetic Biology Market worth $ 11.00 Billion, Globally, by 2028 at 6.60% % CAGR: Verified Market Research™


Global Synthetic Biology Market Overview
Increasing demand of synthetic biology by Biotechnological and Pharmaceutical companies for research and development purposes contributes to the growth of this market. According to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), over 149.8 Billion USD is spent on R&D per year by the pharmaceutical research-based industry. The application of Synthetic Biology techniques in drug discovery and development acts as a growth driver for the Global Synthetic Biology market. In 2015 witnessed the launch of 56 new pharmaceuticals products out of more than 7,000 compounds in development which includes the synthesis of new bio-based products. For instance, Cell-free systems were used to design biosynthetic pathways for the antiviral agent valinomycin.

Jersey , Mexico , Germany , United-states , United-kingdom , California , Canada , France , America , Brammer-bio , Asia-pacific , Edwyne-fernandes

Precigen Reports Fourth Quarter and Full Year 2020 Financial Results


Precigen Reports Fourth Quarter and Full Year 2020 Financial Results
- Company successfully accomplished anticipated 2020 clinical milestones despite challenges due to the ongoing pandemic -
- Strengthened balance sheet with successful public offering while streamlining operations and reducing operating costs -
- Initial data readouts from PRGN-3005 and PRGN-3006 UltraCAR-T® clinical trials demonstrated encouraging expansion, persistence and clinical activity -
- A PRGN-3006 UltraCAR-T patient achieved complete remission with incomplete hematologic recovery (CRi) per ELN criteria -
- Initiated first AdenoVerse™ immunotherapy clinical trial for PRGN-2009 in HPV-associated solid tumors -
- Interim data for AG019 ActoBiotics™ in T1D indicate encouraging trends in C-peptide levels and ability to induce antigen-specific immune modulation following only one treatment cycle of oral AG019 as monotherapy or combination -

United-states , American , Precigen-actobio , Helen-sabzevari , Development-agreement , National-cancer-institute , H-lee-moffitt-cancer-center-research-institute , Drug-administration , Intrexon-corporation , Nasdaq , Cancer-research , American-society-of-hematology

Celiac Disease Drugs Market Competitive Landscape 2020, Global Analysis by Size, Growth Rate, Key Tr


Search jobs
22-Feb-2021
Celiac Disease Drugs Market Competitive Landscape 2020, Global Analysis by Size, Growth Rate, Key Trends, drug type, diagnosis, Treatment and Regional Forecast
Celiac disease is an autoimmune disorder that cause damage and inflammation to the small intestine and mostly found in people who are hereditarily inclined towards gluten. Some of the symptoms of celiac disease are gastrointestinal malfunctions such as diarrhea, abdominal distention, loss of appetite, and among kids’ failure to grow normally and also sometimes loss of lymphocytes. Coeliac disease is triggered when the body reacts to gluten, generally found in wheat and in other grains such as barley and rye.

China , Australia , Japan , United-states , India , United-kingdom , Massachusetts , Americans , America , Asia-pacific , Eliza-hall-institute , Institute-for-protein-design

Synthetic Biology Market Size worth $34.51 Billion | Global Industry Research on Growth, Trends, Opp


Search jobs
03-Feb-2021
Synthetic Biology Market Size worth $34.51 Billion | Global Industry Research on Growth, Trends, Opportunity and Forecast to 2027
Pune, Maharashtra, India, February 3 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:The Global Demand For Synthetic Biology Market In Terms Of Revenue Was Estimated to be USD 7.54 Billion in 2019 and is expected to reach USD 34.51 Billion in 2026, growing at a CAGR of 21.9% from 2020 to 2026.
The Global Synthetic Biology Market is expected to grow at a significant growth rate due to the number of driving factors.
Synthetic biology is a field of science which consists of redesigning of organisms for useful purposes with the help of engineering technique for making new abilities. It is the way of harnessing the power of nature to solve problems in medicine, manufacturing, and agriculture for researchers and companies around the world. Microorganisms harnessed for bioremediation to clean pollutants from water, soil, and air. It is used for designing and constructing new biological parts, devices, and systems as well as for re-designing of existing, natural biological systems for useful purposes. It has applications in various industries like diagnostics, cell reprogramming, therapeutics, enzymes, vaccines, biomaterials, biofuels, fine chemicals, and many more.

Mexico , Germany , Japan , United-states , India , United-kingdom , Pune , Maharashtra , Brazil , China , Italy , Canada

Lawsuit for Investors in Precigen, Inc. (NASDAQ: PGEN) shares announced by Shareholders Foundation

Lawsuit for Investors in Precigen, Inc. (NASDAQ: PGEN) shares announced by Shareholders Foundation
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , Michael-daniels , Shareholders-foundation-inc , Shareholders-foundation , Intrexon-corporation , Nasdaq , Precigen-inc , Securities-laws , Del-rio-north , சான்-டியாகோ

Emphysema Drug Market 2020: To Gain Massive CAGR Growth 2026

Emphysema Drug Market 2020: To Gain Massive CAGR Growth 2026
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Icure-pharmaceuticals-inc , Emphasys-medical-inc , Pfizer-inc , Pulmonx-inc , Intrexon-corporation , Olympus-corporation , Uptake-medical-corporation , Bioxyne-limited , Icure-pharmaceuticals , Kamada-limited , Emphasys-medical